Status | Study |
Terminated |
Study Name: Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer Condition: Recurrent Ovarian Epithelial Cancer Recurrent Ovarian Germ Cell Tumor Date: 2011-12-13 Interventions: Radiation: stereotactic body radiation therapy |
Recruiting |
Study Name: Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors Condition: Diffuse Intrinsic Pontine Glioma PNET Ependymoma Date: 2011-09-30 |
Active, not recruiting |
Study Name: Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer Condition: Stage III Ovarian Epithelial Cancer Stage III Ovarian Germ Cell Tumor Date: 2011-03-07 Interventions: Biological: pUMVC3-hIGFBP-2 multi-epitope plasmid DNA vaccine |
Terminated |
Study Name: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Choriocarcinoma Date: 2010-03-16 Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097 |
Completed |
Study Name: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Choriocarcinoma Date: 2010-02-25 Interventions: Drug: vorinostat Other Names: |
Completed |
Study Name: ARQ 197 for Subjects With Relapsed or Refractory Germ Cell Tumors Condition: Non-CNS Germ Cell Tumors (Seminomas and Nonseminomas) Date: 2010-01-21 Interventions: Drug: Tivantinib (ARQ 197) Capsule, 120 mg, BID (360 mg), approximately 112 days |
Completed |
Study Name: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Condition: Childhood Burkitt Lymphoma Childhood Central Nervous System Choriocarcinoma Date: 2009-10-10 Interventions: Drug: vorinostat Given orally |
Completed |
Study Name: Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors Condition: Recurrent Extragonadal Seminoma Recurrent Malignant Extragonadal Germ Cell Tumor Date: 2009-08-12 Interventions: Drug: Alvocidib Hydrochloride |
Completed |
Study Name: Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment Condition: Childhood Central Nervous System Choriocarcinoma Childhood Central Nervous System Embryonal Date: 2009-06-27 Interventions: Drug: pazopanib hydrochloride |
Active, not recruiting |
Study Name: Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer Condition: HER2-positive Breast Cancer Stage III Ovarian Epithelial Cancer Date: 2007-02-15 Interventions: Biological: pNGVL3-hICD vaccine |